Illumina Stock Price, News & Analysis (NASDAQ:ILMN)

$216.55 5.70 (2.70 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$216.55
Today's Range$210.18 - $216.72
52-Week Range$126.18 - $230.72
Volume1.49 million shs
Average Volume953,482 shs
Market Capitalization$31.32 billion
P/E Ratio62.73
Dividend YieldN/A
Beta0.79

About Illumina (NASDAQ:ILMN)

Illumina logoIllumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

Receive ILMN News and Ratings via Email

Sign-up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolNASDAQ:ILMN
CUSIP45232710
Phone858-202-4500

Debt

Debt-to-Equity Ratio0.41%
Current Ratio4.22%
Quick Ratio3.73%

Price-To-Earnings

Trailing P/E Ratio62.73
Forward P/E Ratio57.75
P/E Growth3.54

Sales & Book Value

Annual Sales$2.40 billion
Price / Sales13.18
Cash Flow$4.63 per share
Price / Cash46.77
Book Value$15.45 per share
Price / Book14.02

Profitability

Trailing EPS$5.34
Net Income$462.64 million
Net Margins30.34%
Return on Equity19.42%
Return on Assets10.74%

Miscellaneous

Employees5,500
Outstanding Shares146,000,000

Illumina (NASDAQ:ILMN) Frequently Asked Questions

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

How were Illumina's earnings last quarter?

Illumina, Inc. (NASDAQ:ILMN) released its earnings results on Tuesday, October, 24th. The life sciences company reported $1.11 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.99 by $0.12. The life sciences company had revenue of $714 million for the quarter, compared to analysts' expectations of $692.77 million. Illumina had a return on equity of 19.42% and a net margin of 30.34%. The business's revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.97 earnings per share. View Illumina's Earnings History.

When will Illumina make its next earnings announcement?

Illumina is scheduled to release their next quarterly earnings announcement on Monday, January, 29th 2018. View Earnings Estimates for Illumina.

What guidance has Illumina issued on next quarter's earnings?

Illumina issued an update on its FY17 earnings guidance on Tuesday, October, 24th. The company provided earnings per share guidance of $3.73-3.78 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.65. The company issued revenue guidance of +13% to ~$2.71 billion, compared to the consensus revenue estimate of $2.68 billion.

Where is Illumina's stock going? Where will Illumina's stock price be in 2017?

20 equities research analysts have issued 12 month price targets for Illumina's stock. Their predictions range from $125.00 to $250.00. On average, they expect Illumina's stock price to reach $200.00 in the next twelve months. View Analyst Ratings for Illumina.

What are Wall Street analysts saying about Illumina stock?

Here are some recent quotes from research analysts about Illumina stock:

  • 1. According to Zacks Investment Research, "Post a promising third-quarter show, we expect Illumina to maintain its growth momentum on continued uptake of sequencing consumables, instruments and microarray portfolios. Management is also hopeful that recent launches like NovaSeq S4 flow cell and reagent kit for its NovaSeq 6000 System will drive demand for NovaSeq. We look forward to the launch of NovaSeq Xp workflow. Also, the company’s launch of Nextera DNA Flex buoys optimism. Moreover, the company recently partnered with Telegraph Hill Partners to set up an independent entity. Accordingly, over the last three months, Illumina has been trading above the broader industry. On the flip side, weak margins owing to the NovaSeq launch, higher array services revenues and unfavorable product mix within sequencing consumables will continue to act as deterrents." (12/5/2017)
  • 2. Canaccord Genuity analysts commented, "Shipments to China grew +16% and we believe China is likely to be a double-digit grower for ILMN over the next several years, driven by the Chinese Precision Medicine Initiative," (8/7/2017)

Who are some of Illumina's key competitors?

Who are Illumina's key executives?

Illumina's management team includes the folowing people:

  • Jay T. Flatley, Executive Chairman of the Board (Age 64)
  • Francis A. deSouza, President, Chief Executive Officer, Director (Age 46)
  • Sam Samad, Chief Financial Officer, Senior Vice President (Age 47)
  • Marc A. Stapley, Executive Vice President, Chief Administrative Officer (Age 46)
  • Garret Hampton Ph.D., Executive Vice President - Clinical Genomics (Age 51)
  • Omead Ostadan, Executive Vice President - Operations, Products and Strategy (Age 45)
  • Mostafa Ronaghi Ph.D., Chief Technology Officer, Senior Vice President (Age 47)
  • Charles E. Dadswell, Senior Vice President, General Counsel, Secretary (Age 57)
  • Mark Van Oene, Senior Vice President, Chief Commercial Officer
  • Karen K. McGinnis, Vice President, Chief Accounting Officer, Principal Accounting Officer (Age 51)

Who owns Illumina stock?

Illumina's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (12.52%), Edgewood Management LLC (3.52%), Jennison Associates LLC (2.78%), Ameriprise Financial Inc. (1.72%), Mitsubishi UFJ Trust & Banking Corp (0.69%) and Legal & General Group Plc (0.47%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, David R Walt, Frances Arnold, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Nicholas Naclerio, Oene Mark Van, Omead Ostadan, Paul L Bianchi, Robert S Epstein and Roy A Whitfield. View Institutional Ownership Trends for Illumina.

Who sold Illumina stock? Who is selling Illumina stock?

Illumina's stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Baillie Gifford & Co., SG Americas Securities LLC, Stifel Financial Corp, Edgewood Management LLC, State Treasurer State of Michigan, PGGM Investments and Douglas Lane & Associates LLC. Company insiders that have sold Illumina company stock in the last year include A Blaine Bowman, Charles Dadswell, Daniel Bradbury, Frances Arnold, Jay T Flatley, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan and Robert S Epstein. View Insider Buying and Selling for Illumina.

Who bought Illumina stock? Who is buying Illumina stock?

Illumina's stock was acquired by a variety of institutional investors in the last quarter, including American Century Companies Inc., Parametric Portfolio Associates LLC, Los Angeles Capital Management & Equity Research Inc., Ameriprise Financial Inc., Scout Investments Inc., Axiom International Investors LLC DE, Sei Investments Co. and Eagle Asset Management Inc.. View Insider Buying and Selling for Illumina.

How do I buy Illumina stock?

Shares of Illumina can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Illumina's stock price today?

One share of Illumina stock can currently be purchased for approximately $216.55.

How big of a company is Illumina?

Illumina has a market capitalization of $31.32 billion and generates $2.40 billion in revenue each year. The life sciences company earns $462.64 million in net income (profit) each year or $5.34 on an earnings per share basis. Illumina employs 5,500 workers across the globe.

How can I contact Illumina?

Illumina's mailing address is 5200 ILLUMINA WAY, SAN DIEGO CA, 92122. The life sciences company can be reached via phone at 858-202-4500 or via email at [email protected]


MarketBeat Community Rating for Illumina (ILMN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  690 (Vote Outperform)
Underperform Votes:  685 (Vote Underperform)
Total Votes:  1,375
MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Illumina (NASDAQ:ILMN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.482.482.392.30
Ratings Breakdown: 1 Sell Rating(s)
9 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
9 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
10 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
10 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $195.65$195.00$173.89$161.63
Price Target Upside: 8.99% downside4.81% downside18.72% downside10.23% downside

Illumina (NASDAQ:ILMN) Consensus Price Target History

Price Target History for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/14/2017Morgan StanleyBoost Price TargetUnderweight$122.00 -> $135.00MediumView Rating Details
10/25/2017CitigroupBoost Price TargetNeutral$180.00 -> $220.00N/AView Rating Details
10/25/2017BarclaysBoost Price TargetEqual Weight$150.00 -> $185.00N/AView Rating Details
10/25/2017Bank of AmericaBoost Price TargetBuy$215.00 -> $240.00N/AView Rating Details
10/25/2017Wells Fargo & CompanyReiterated RatingMarket Perform$200.00 -> $205.00N/AView Rating Details
10/25/2017Robert W. BairdUpgradeNeutral -> Outperform$184.00 -> $228.00N/AView Rating Details
10/23/2017Janney Montgomery ScottUpgradeSell -> NeutralN/AView Rating Details
10/23/2017Deutsche BankUpgradeHold -> Buy$195.00 -> $160.00N/AView Rating Details
10/12/2017Canaccord GenuityReiterated RatingBuy$215.00 -> $230.00N/AView Rating Details
10/9/2017Piper Jaffray CompaniesReiterated RatingOverweight$202.00 -> $226.00N/AView Rating Details
9/26/2017Goldman Sachs GroupReiterated RatingNeutral -> Neutral$200.00LowView Rating Details
9/13/2017ArgusBoost Price TargetBuy$205.00 -> $235.00LowView Rating Details
9/12/2017Leerink SwannReiterated RatingOutperform$207.00 -> $225.00LowView Rating Details
8/2/2017CowenReiterated RatingOutperform$200.00HighView Rating Details
8/2/2017J P Morgan Chase & CoReiterated RatingOverweight$250.00HighView Rating Details
8/2/2017First AnalysisUpgradeUnderweight -> Equal Weight$176.00HighView Rating Details
4/26/2017Cantor FitzgeraldBoost Price TargetNeutral -> Neutral$155.00 -> $170.00HighView Rating Details
3/19/2017BTIG ResearchReiterated RatingHoldMediumView Rating Details
2/27/2017Evercore ISIUpgradeHold -> Buy$190.00N/AView Rating Details
1/6/2017CL KingUpgradeNeutral -> BuyN/AView Rating Details
7/27/2016MizuhoBoost Price TargetNeutral$138.00 -> $148.00N/AView Rating Details
5/4/2016Stifel NicolausReiterated RatingBuy$215.00 -> $160.00N/AView Rating Details
5/3/2016NomuraLower Price TargetBuy$210.00 -> $180.00N/AView Rating Details
4/22/2016Avondale PartnersReiterated RatingMarket Perform$175.00 -> $160.00N/AView Rating Details
(Data available from 12/15/2015 forward)

Earnings

Illumina (NASDAQ:ILMN) Earnings History and Estimates Chart

Earnings by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ ILMN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/29/2018$1.19N/AView Earnings Details
10/24/2017Q3 2017$0.99$1.11$692.77 million$714.00 millionViewN/AView Earnings Details
8/1/2017Q2 2017$0.68$0.82$642.38 million$662.00 millionViewListenView Earnings Details
4/25/2017Q1 2017$0.64$0.64$590.51 million$598.00 millionViewN/AView Earnings Details
1/31/2017Q416$0.82$0.85$612.50 million$619.00 millionViewListenView Earnings Details
11/1/2016Q316$0.87$0.97$628.06 million$607.00 millionViewListenView Earnings Details
7/26/2016Q2$0.73$0.86$31.91 million$600.00 millionViewListenView Earnings Details
5/3/2016Q1$0.74$0.71$596.33 million$572.00 millionViewListenView Earnings Details
2/2/2016Q415$0.82$0.81$576.39 million$591.50 millionViewListenView Earnings Details
10/20/2015Q315$0.79$0.80$568.60 million$550.00 millionViewListenView Earnings Details
7/21/2015Q215$0.77$0.80$541.05 million$539.00 millionViewListenView Earnings Details
4/21/2015Q115$0.72$0.91$524.35 million$539.00 millionViewListenView Earnings Details
1/27/2015Q414$0.78$0.87$503.83 million$512.00 millionViewListenView Earnings Details
10/20/2014Q314$0.56$0.77$451.20 million$481.00 millionViewListenView Earnings Details
7/23/2014Q214$0.51$0.57$426.50 million$448.00 millionViewListenView Earnings Details
4/22/2014Q114$0.44$0.53$391.50 million$421.00 millionViewListenView Earnings Details
1/28/2014Q413$0.44$0.45$382.06 million$387.00 millionViewListenView Earnings Details
10/21/2013Q313$0.40$0.45$343.42 million$357.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.40$0.43$331.77 million$346.09 millionViewListenView Earnings Details
4/22/2013Q1 2013$0.39$0.46$310.64 million$330.96 millionViewListenView Earnings Details
1/28/2013Q4 2012$0.41$0.42$303.13 million$309.30 millionViewListenView Earnings Details
10/23/2012$0.39$0.41ViewN/AView Earnings Details
7/24/2012$0.36$0.40ViewN/AView Earnings Details
4/23/2012$0.32$0.36ViewN/AView Earnings Details
2/7/2012$0.30$0.35ViewN/AView Earnings Details
10/25/2011$0.23$0.22ViewN/AView Earnings Details
4/26/2011$0.31$0.35ViewN/AView Earnings Details
2/8/2011$0.29$0.29ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Illumina (NASDAQ:ILMN) Earnings Estimates

2017 EPS Consensus Estimate: $3.61
2018 EPS Consensus Estimate: $4.50
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.63$0.82$0.69
Q2 20173$0.65$0.85$0.72
Q3 20173$0.99$1.06$1.02
Q4 20173$1.16$1.19$1.18
Q1 20183$1.02$1.08$1.05
Q2 20183$1.02$1.14$1.07
Q3 20183$1.14$1.20$1.18
Q4 20182$1.19$1.23$1.21
Q1 20191$1.28$1.28$1.28
Q2 20191$1.31$1.31$1.31
Q3 20191$1.33$1.33$1.33
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Illumina (NASDAQ:ILMN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Illumina (NASDAQ ILMN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.89%
Institutional Ownership Percentage: 91.75%
Insider Trades by Quarter for Illumina (NASDAQ:ILMN)
Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ ILMN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/5/2017Jay T FlatleyDirectorSell20,000$212.55$4,251,000.00View SEC Filing  
12/4/2017Charles DadswellSVPSell145$225.33$32,672.85View SEC Filing  
12/4/2017Marc StapleyEVPSell2,000$219.88$439,760.00View SEC Filing  
12/1/2017Omead OstadanEVPSell3,540$226.91$803,261.40View SEC Filing  
12/1/2017Robert S EpsteinDirectorSell1,250$226.55$283,187.50View SEC Filing  
11/21/2017Jay T FlatleyDirectorSell20,000$211.35$4,227,000.00View SEC Filing  
11/15/2017Marc StapleyEVPSell2,000$205.48$410,960.00View SEC Filing  
11/15/2017Oene Mark VanSVPSell1,250$207.76$259,700.00View SEC Filing  
11/13/2017Oene Mark VanSVPSell1,232$207.78$255,984.96View SEC Filing  
11/7/2017Jay T FlatleyDirectorSell20,000$210.59$4,211,800.00View SEC Filing  
11/3/2017Charles DadswellSVPSell1,609$207.88$334,478.92View SEC Filing  
10/26/2017Marc StapleyEVPSell2,000$206.88$413,760.00View SEC Filing  
10/24/2017Jay T FlatleyDirectorSell20,000$210.43$4,208,600.00View SEC Filing  
10/12/2017Oene Mark VanSVPSell1,250$207.21$259,012.50View SEC Filing  
10/10/2017Jay T FlatleyDirectorSell20,000$203.27$4,065,400.00View SEC Filing  
10/3/2017Charles DadswellSVPSell145$202.23$29,323.35View SEC Filing  
9/26/2017Jay T FlatleyDirectorSell20,000$200.16$4,003,200.00View SEC Filing  
9/12/2017Jay T FlatleyDirectorSell20,000$211.11$4,222,200.00View SEC Filing  
9/12/2017Oene Mark VanSVPSell9,729$211.33$2,056,029.57View SEC Filing  
9/7/2017Mostafa RonaghiSVPSell20,000$210.00$4,200,000.00View SEC Filing  
9/5/2017Charles DadswellSVPSell145$205.71$29,827.95View SEC Filing  
9/5/2017Marc StapleyEVPSell2,000$205.93$411,860.00View SEC Filing  
8/31/2017Michel BouchardInsiderSell5,390$202.11$1,089,372.90View SEC Filing  
8/30/2017Michel BouchardCAOSell616$200.00$123,200.00View SEC Filing  
8/29/2017Jay T FlatleyDirectorSell22,540$195.21$4,400,033.40View SEC Filing  
8/28/2017Jay T FlatleyDirectorSell2,540$197.39$501,370.60View SEC Filing  
8/15/2017Jay T FlatleyDirectorSell20,000$194.73$3,894,600.00View SEC Filing  
8/7/2017Omead OstadanEVPSell1,671$195.26$326,279.46View SEC Filing  
8/3/2017Charles DadswellSVPSell1,609$197.00$316,973.00View SEC Filing  
8/3/2017Marc StapleyEVPSell2,000$196.80$393,600.00View SEC Filing  
8/2/2017Jay T FlatleyDirectorSell20,000$176.43$3,528,600.00View SEC Filing  
8/2/2017Michel BouchardInsiderSell3,131$194.97$610,451.07View SEC Filing  
8/2/2017Mostafa RonaghiSVPSell10,000$195.00$1,950,000.00View SEC Filing  
7/18/2017Jay T FlatleyDirectorSell15,000$170.77$2,561,550.00View SEC Filing  
7/14/2017Marc StapleyEVPSell2,000$173.56$347,120.00View SEC Filing  
7/7/2017Omead OstadanEVPSell1,672$172.73$288,804.56View SEC Filing  
7/5/2017Jay T FlatleyDirectorSell15,000$172.92$2,593,800.00View SEC Filing  
7/3/2017Charles DadswellSVPSell145$174.24$25,264.80View SEC Filing  
6/23/2017Michel BouchardInsiderSell246$185.00$45,510.00View SEC Filing  
6/22/2017Jay T FlatleyDirectorSell20,000$178.21$3,564,200.00View SEC Filing  
6/12/2017Marc StapleyEVPSell2,000$170.85$341,700.00View SEC Filing  
6/8/2017Michel BouchardInsiderSell246$178.91$44,011.86View SEC Filing  
6/6/2017Jay T FlatleyDirectorSell20,000$180.24$3,604,800.00View SEC Filing  
6/5/2017Charles DadswellSVPSell145$184.75$26,788.75View SEC Filing  
6/1/2017Jay T FlatleyDirectorSell3,320$180.55$599,426.00View SEC Filing  
5/25/2017Frances ArnoldDirectorSell825$174.77$144,185.25View SEC Filing  
5/23/2017Jay T FlatleyDirectorSell15,000$175.53$2,632,950.00View SEC Filing  
5/10/2017A Blaine BowmanDirectorSell2,300$181.61$417,703.00View SEC Filing  
5/9/2017Jay T FlatleyDirectorSell20,000$184.14$3,682,800.00View SEC Filing  
5/9/2017Michel BouchardInsiderSell5,740$184.68$1,060,063.20View SEC Filing  
5/3/2017Charles DadswellSVPSell1,609$187.07$300,995.63View SEC Filing  
4/12/2017A Blaine BowmanDirectorSell3,000$172.72$518,160.00View SEC Filing  
4/7/2017Daniel BradburyDirectorSell600$172.79$103,674.00View SEC Filing  
3/24/2017Omead OstadanEVPSell1,672$170.00$284,240.00View SEC Filing  
3/21/2017Daniel BradburyDirectorSell600$163.56$98,136.00View SEC Filing  
2/17/2017Daniel BradburyDirectorSell600$162.80$97,680.00View SEC Filing  
2/13/2017Omead OstadanEVPSell2,173$163.10$354,416.30View SEC Filing  
2/8/2017A Blaine BowmanDirectorSell3,000$162.74$488,220.00View SEC Filing  
2/6/2017Charles DadswellSVPSell572$161.26$92,240.72View SEC Filing  
1/30/2017Omead OstadanEVPSell259$160.90$41,673.10View SEC Filing  
1/19/2017Omead OstadanEVPSell2,378$160.06$380,622.68View SEC Filing  
1/11/2017A Blaine BowmanDirectorSell3,000$162.89$488,670.00View SEC Filing  
1/10/2017Charles DadswellSVPSell116$161.60$18,745.60View SEC Filing  
1/4/2017Daniel BradburyDirectorSell600$135.01$81,006.00View SEC Filing  
12/15/2016Omead OstadanEVPSell2,000$126.16$252,320.00View SEC Filing  
12/12/2016Daniel BradburyDirectorSell600$123.42$74,052.00View SEC Filing  
12/8/2016Omead OstadanEVPSell3,000$121.63$364,890.00View SEC Filing  
12/1/2016Omead OstadanEVPSell3,000$133.30$399,900.00View SEC Filing  
11/14/2016Daniel BradburyDirectorSell600$136.34$81,804.00View SEC Filing  
10/7/2016Daniel BradburyDirectorSell600$184.36$110,616.00View SEC Filing  
10/4/2016Charles DadswellSVPSell116$182.38$21,156.08View SEC Filing  
9/20/2016Robert S EpsteinDirectorSell300$174.29$52,287.00View SEC Filing  
9/15/2016Marc StapleyEVPSell1,270$172.87$219,544.90View SEC Filing  
9/14/2016Daniel BradburyDirectorSell600$171.25$102,750.00View SEC Filing  
8/23/2016Jay T FlatleyDirectorSell20,000$172.99$3,459,800.00View SEC Filing  
8/22/2016Robert S EpsteinDirectorSell300$170.27$51,081.00View SEC Filing  
8/17/2016Daniel BradburyDirectorSell600$168.42$101,052.00View SEC Filing  
8/15/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00View SEC Filing  
8/12/2016Roy A WhitfieldDirectorSell4,000$167.22$668,880.00View SEC Filing  
8/9/2016Jay T FlatleyDirectorSell10,000$165.97$1,659,700.00View SEC Filing  
8/1/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00View SEC Filing  
7/27/2016Charles DadswellSVPSell8,632$155.00$1,337,960.00View SEC Filing  
7/26/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00View SEC Filing  
7/20/2016Robert S EpsteinDirectorSell1,200$150.00$180,000.00View SEC Filing  
7/18/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00View SEC Filing  
7/14/2016A Blaine BowmanDirectorSell5,000$147.14$735,700.00View SEC Filing  
7/11/2016Christian O HenryEVPSell716$141.89$101,593.24View SEC Filing  
6/16/2016A Blaine BowmanDirectorSell5,000$135.08$675,400.00View SEC Filing  
6/15/2016Christian O HenryEVPSell2,141$137.90$295,243.90View SEC Filing  
6/13/2016Roy A WhitfieldDirectorSell3,800$140.44$533,672.00View SEC Filing  
6/1/2016Karin EasthamDirectorSell5,000$145.35$726,750.00View SEC Filing  
5/25/2016Christian O HenryEVPSell2,141$144.73$309,866.93View SEC Filing  
5/17/2016Christian O HenryEVPSell2,141$140.84$301,538.44View SEC Filing  
5/12/2016A Blaine BowmanDirectorSell5,000$137.11$685,550.00View SEC Filing  
4/27/2016Christian O HenryEVPSell2,141$138.46$296,442.86View SEC Filing  
4/18/2016Christian O HenryEVPSell2,141$176.01$376,837.41View SEC Filing  
4/18/2016Paul L BianchiVPSell1,884$175.00$329,700.00View SEC Filing  
4/14/2016A Blaine BowmanDirectorSell5,000$172.94$864,700.00View SEC Filing  
4/13/2016Christian O HenryEVPSell12,500$175.00$2,187,500.00View SEC Filing  
4/13/2016Paul L BianchiVPSell6,681$175.00$1,169,175.00View SEC Filing  
4/12/2016Jay T FlatleyCEOSell20,000$170.05$3,401,000.00View SEC Filing  
4/12/2016Roy A WhitfieldDirectorSell4,000$170.00$680,000.00View SEC Filing  
4/7/2016David R WaltDirectorSell4,000$168.90$675,600.00View SEC Filing  
4/5/2016Christian O HenryEVPSell2,141$166.07$355,555.87View SEC Filing  
4/4/2016Charles DadswellSVPSell8,382$167.81$1,406,583.42View SEC Filing  
3/23/2016Christian O HenryEVPSell2,141$155.05$331,962.05View SEC Filing  
3/22/2016Jay T FlatleyCEOSell10,000$154.18$1,541,800.00View SEC Filing  
3/21/2016Daniel BradburyDirectorSell1,200$155.63$186,756.00View SEC Filing  
3/21/2016Nicholas NaclerioSVPSell4,520$154.25$697,210.00View SEC Filing  
3/17/2016A Blaine BowmanDirectorSell5,000$145.24$726,200.00View SEC Filing  
3/15/2016David R WaltDirectorSell4,000$149.99$599,960.00View SEC Filing  
3/14/2016Christian O HenryEVPSell5,892$155.91$918,621.72View SEC Filing  
3/8/2016Charles DadswellSVPSell8,382$155.63$1,304,490.66View SEC Filing  
3/8/2016Jay T FlatleyCEOSell10,000$154.49$1,544,900.00View SEC Filing  
3/8/2016Omead OstadanEVPSell4,516$156.09$704,902.44View SEC Filing  
3/7/2016Charles DadswellSVPSell116$155.00$17,980.00View SEC Filing  
2/23/2016Jay T FlatleyCEOSell10,000$152.49$1,524,900.00View SEC Filing  
2/17/2016Daniel BradburyDirectorSell1,700$154.74$263,058.00View SEC Filing  
2/12/2016Roy A. WhitfieldDirectorSell3,750$140.30$526,125.00View SEC Filing  
2/1/2016Omead OstadanEVPSell1,108$156.73$173,656.84View SEC Filing  
1/26/2016Jay T. FlatleyCEOSell20,000$171.70$3,434,000.00View SEC Filing  
1/13/2016Jay T. FlatleyCEOSell20,000$168.81$3,376,200.00View SEC Filing  
1/4/2016Daniel BradburyDirectorSell1,700$182.80$310,760.00View SEC Filing  
12/28/2015Charles DadswellSVPSell168$188.63$31,689.84View SEC Filing  
12/22/2015Jay T. FlatleyCEOSell25,000$185.38$4,634,500.00View SEC Filing  
12/14/2015Roy A. WhitfieldDirectorSell3,750$175.07$656,512.50View SEC Filing  
12/11/2015Omead OstadanEVPSell260$179.90$46,774.00View SEC Filing  
12/11/2015Paul L BianchiVPSell197$179.90$35,440.30View SEC Filing  
12/10/2015Daniel BradburyDirectorSell1,700$182.37$310,029.00View SEC Filing  
12/8/2015Jay T. FlatleyCEOSell25,000$177.11$4,427,750.00View SEC Filing  
11/27/2015Robert S EpsteinDirectorSell1,000$185.56$185,560.00View SEC Filing  
11/25/2015Jay T. FlatleyCEOSell5,000$180.00$900,000.00View SEC Filing  
11/24/2015Jay T. FlatleyCEOSell20,000$173.27$3,465,400.00View SEC Filing  
11/16/2015Jay T. FlatleyCEOSell10,000$170.00$1,700,000.00View SEC Filing  
11/10/2015Daniel BradburyDirectorSell1,700$154.03$261,851.00View SEC Filing  
11/10/2015Jay T. FlatleyCEOSell10,000$154.58$1,545,800.00View SEC Filing  
11/3/2015Charles DadswellSVPSell158$150.00$23,700.00View SEC Filing  
10/15/2015Jay T. FlatleyCEOSell10,000$150.00$1,500,000.00View SEC Filing  
10/7/2015Daniel BradburyDirectorSell1,700$145.81$247,877.00View SEC Filing  
9/29/2015David R WaltDirectorSell2,000$171.65$343,300.00View SEC Filing  
9/22/2015Jay T. FlatleyCEOSell25,000$192.79$4,819,750.00View SEC Filing  
9/15/2015David R WaltDirectorSell2,000$206.45$412,900.00View SEC Filing  
9/14/2015Daniel BradburyDirectorSell1,700$203.89$346,613.00View SEC Filing  
9/9/2015Paul L. BianchiVPSell1,245$199.32$248,153.40View SEC Filing  
9/8/2015Jay T. FlatleyCEOSell25,000$194.87$4,871,750.00View SEC Filing  
9/8/2015Karin EasthamDirectorSell4,300$195.76$841,768.00View SEC Filing  
9/4/2015Roy A. WhitfieldDirectorSell4,500$192.63$866,835.00View SEC Filing  
9/1/2015David R WaltDirectorSell2,000$195.08$390,160.00View SEC Filing  
8/27/2015Jay T. FlatleyCEOSell25,000$200.16$5,004,000.00View SEC Filing  
8/18/2015David R WaltDirectorSell2,000$206.89$413,780.00View SEC Filing  
8/17/2015Daniel BradburyDirectorSell1,700$208.14$353,838.00View SEC Filing  
8/13/2015Jay T FlatleyCEOSell25,000$207.85$5,196,250.00View SEC Filing  
8/5/2015Roy A. WhitfieldDirectorSell4,500$215.22$968,490.00View SEC Filing  
7/24/2015A Blaine BowmanDirectorSell3,000$221.47$664,410.00View SEC Filing  
7/23/2015Jay T FlatleyCEOSell25,000$214.87$5,371,750.00View SEC Filing  
7/21/2015David R WaltDirectorSell12,000$235.24$2,822,880.00View SEC Filing  
7/17/2015Mostafa RonaghiSVPSell1,200$235.00$282,000.00View SEC Filing  
7/16/2015Christian O HenrySVPSell5,390$229.61$1,237,597.90View SEC Filing  
7/15/2015Mostafa RonaghiSVPSell3,000$227.19$681,570.00View SEC Filing  
7/14/2015David R WaltDirectorSell10,000$227.39$2,273,900.00View SEC Filing  
7/13/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
7/13/2015Michel BouchardCAOSell1,400$222.75$311,850.00View SEC Filing  
7/10/2015Omead OstadanSVPSell1,110$219.81$243,989.10View SEC Filing  
7/10/2015Robert S EpsteinDirectorSell2,000$219.81$439,620.00View SEC Filing  
7/9/2015Jay T FlatleyCEOSell25,000$218.10$5,452,500.00View SEC Filing  
7/7/2015David R WaltDirectorSell10,000$220.22$2,202,200.00View SEC Filing  
7/6/2015Daniel BradburyDirectorSell1,700$219.70$373,490.00View SEC Filing  
6/30/2015David R WaltDirectorSell10,000$217.64$2,176,400.00View SEC Filing  
6/25/2015Jay T FlatleyCEOSell25,000$220.34$5,508,500.00View SEC Filing  
6/24/2015A Blaine BowmanDirectorSell3,000$221.43$664,290.00View SEC Filing  
6/24/2015Christian O HenrySVPSell5,084$221.07$1,123,919.88View SEC Filing  
6/23/2015David R WaltDirectorSell12,000$220.11$2,641,320.00View SEC Filing  
6/17/2015Christian O HenrySVPSell3,751$215.71$809,128.21View SEC Filing  
6/16/2015David R WaltDirectorSell10,000$215.14$2,151,400.00View SEC Filing  
6/15/2015Nicholas NaclerioSVPSell6,590$214.33$1,412,434.70View SEC Filing  
6/15/2015Paul L BianchiVPSell3,408$215.83$735,548.64View SEC Filing  
6/12/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
6/12/2015Michel BouchardCAOSell1,400$216.11$302,554.00View SEC Filing  
6/11/2015Jay T FlatleyCEOSell25,000$216.41$5,410,250.00View SEC Filing  
6/10/2015Christian O HenrySVPSell10,000$214.94$2,149,400.00View SEC Filing  
6/10/2015Robert S EpsteinDirectorSell2,000$214.24$428,480.00View SEC Filing  
6/5/2015Roy A WhitfieldDirectorSell4,500$207.49$933,705.00View SEC Filing  
6/2/2015David R WaltDirectorSell10,000$204.42$2,044,200.00View SEC Filing  
6/1/2015Karin EasthamDirectorSell5,000$205.24$1,026,200.00View SEC Filing  
5/29/2015Daniel BradburyDirectorSell1,700$206.62$351,254.00View SEC Filing  
5/28/2015Jay T FlatleyCEOSell25,000$208.78$5,219,500.00View SEC Filing  
5/22/2015A Blaine BowmanDirectorSell3,000$204.58$613,740.00View SEC Filing  
5/19/2015David R WaltDirectorSell10,000$202.00$2,020,000.00View SEC Filing  
5/14/2015Christian O HenrySVPSell3,751$198.52$744,648.52View SEC Filing  
5/14/2015Jay T FlatleyCEOSell25,000$197.76$4,944,000.00View SEC Filing  
5/13/2015Paul L BianchiVPSell3,356$197.14$661,601.84View SEC Filing  
5/11/2015Robert S EpsteinDirectorSell2,000$196.49$392,980.00View SEC Filing  
4/28/2015David R WaltDirectorSell7,000$183.88$1,287,160.00View SEC Filing  
4/24/2015A Blaine BowmanDirectorSell3,000$190.73$572,190.00View SEC Filing  
4/23/2015Jay T FlatleyCEOSell25,000$189.57$4,739,250.00View SEC Filing  
4/21/2015David R WaltDirectorSell10,000$197.95$1,979,500.00View SEC Filing  
4/15/2015Christian O HenrySVPSell3,751$189.02$709,014.02View SEC Filing  
4/14/2015David R WaltDirectorSell7,000$188.23$1,317,610.00View SEC Filing  
4/13/2015Marc StapleyCFOSell3,000$190.12$570,360.00View SEC Filing  
4/13/2015Michel BouchardCAOSell1,400$188.61$264,054.00View SEC Filing  
4/13/2015Paul L BianchiVPSell3,390$187.22$634,675.80View SEC Filing  
4/10/2015Robert S EpsteinDirectorSell2,000$186.99$373,980.00View SEC Filing  
4/9/2015Jay T FlatleyCEOSell25,000$184.55$4,613,750.00View SEC Filing  
4/8/2015Daniel BradburyDirectorSell1,700$185.32$315,044.00View SEC Filing  
4/7/2015David R WaltDirectorSell5,000$184.28$921,400.00View SEC Filing  
4/6/2015Roy A WhitfieldDirectorSell4,600$181.32$834,072.00View SEC Filing  
3/26/2015Jay T FlatleyCEOSell25,000$181.34$4,533,500.00View SEC Filing  
3/24/2015David R WaltDirectorSell5,000$192.16$960,800.00View SEC Filing  
3/17/2015A Blaine BowmanDirectorSell3,000$192.30$576,900.00View SEC Filing  
3/16/2015Gerald MoellerDirectorSell2,700$193.36$522,072.00View SEC Filing  
3/16/2015Nicholas NaclerioSVPSell6,590$193.94$1,278,064.60View SEC Filing  
3/13/2015Paul L BianchiVPSell3,390$186.67$632,811.30View SEC Filing  
3/12/2015Marc StapleyCFOSell3,314$189.01$626,379.14View SEC Filing  
3/10/2015Richard KlausnerSVPSell1,186$191.75$227,415.50View SEC Filing  
3/10/2015Robert S EpsteinDirectorSell3,000$191.75$575,250.00View SEC Filing  
2/26/2015Jay T FlatleyCEOSell25,000$195.73$4,893,250.00View SEC Filing  
2/12/2015Jay T FlatleyCEOSell25,000$194.64$4,866,000.00View SEC Filing  
2/3/2015David R WaltDirectorSell7,000$190.89$1,336,230.00View SEC Filing  
2/2/2015Karin EasthamDirectorSell10,000$192.77$1,927,700.00View SEC Filing  
2/2/2015Nicholas NaclerioSVPSell15,250$194.37$2,964,142.50View SEC Filing  
1/27/2015Charles DadswellSVPSell224$198.90$44,553.60View SEC Filing  
1/27/2015David R WaltDirectorSell4,000$201.76$807,040.00View SEC Filing  
1/22/2015Jay T FlatleyCEOSell25,000$188.48$4,712,000.00View SEC Filing  
1/20/2015William H RastetterDirectorSell16,000$188.99$3,023,840.00View SEC Filing  
1/15/2015Marc StapleyCFOSell1,422$181.62$258,263.64View SEC Filing  
1/8/2015Jay T FlatleyCEOSell25,000$197.62$4,940,500.00View SEC Filing  
1/6/2015David R WaltDirectorSell6,000$188.55$1,131,300.00View SEC Filing  
1/2/2015Karin EasthamDirectorSell10,000$185.63$1,856,300.00View SEC Filing  
12/30/2014David R WaltDirectorSell5,000$186.95$934,750.00View SEC Filing  
12/29/2014Gerald MoellerDirectorSell8,000$187.05$1,496,400.00View SEC Filing  
12/26/2014Jay T FlatleyCEOSell25,000$186.71$4,667,750.00View SEC Filing  
12/23/2014David R WaltDirectorSell7,000$184.55$1,291,850.00View SEC Filing  
12/16/2014David R WaltDirectorSell5,000$178.35$891,750.00View SEC Filing  
12/15/2014Marc StapleyCFOSell1,422$181.09$257,509.98View SEC Filing  
12/11/2014Jay T FlatleyCEOSell25,000$185.79$4,644,750.00View SEC Filing  
12/9/2014David R WaltDirectorSell7,000$186.75$1,307,250.00View SEC Filing  
12/8/2014Daniel BradburyDirectorSell1,600$190.14$304,224.00View SEC Filing  
12/4/2014Karin EasthamDirectorSell10,000$191.87$1,918,700.00View SEC Filing  
12/1/2014Mostafa RonaghiSVPSell10,000$188.46$1,884,600.00View SEC Filing  
11/26/2014Paul L BianchiSVPSell1,626$189.20$307,639.20View SEC Filing  
11/17/2014Roy A WhitfieldDirectorSell4,000$178.26$713,040.00View SEC Filing  
11/14/2014Marc StapleyCFOSell1,422$181.13$257,566.86View SEC Filing  
11/13/2014Daniel BradburyDirectorSell2,100$186.88$392,448.00View SEC Filing  
11/13/2014Jay T FlatleyCEOSell25,000$189.32$4,733,000.00View SEC Filing  
11/3/2014Michel BouchardCAOSell631$195.68$123,474.08View SEC Filing  
11/3/2014Mostafa RonaghiSVPSell10,000$195.66$1,956,600.00View SEC Filing  
10/30/2014Daniel BradburyDirectorSell2,100$191.83$402,843.00View SEC Filing  
10/23/2014Jay T FlatleyCEOSell25,000$189.54$4,738,500.00View SEC Filing  
10/13/2014Daniel BradburyDirectorSell2,100$152.03$319,263.00View SEC Filing  
10/9/2014Jay T FlatleyCEOSell25,000$163.49$4,087,250.00View SEC Filing  
10/7/2014A Blaine BowmanDirectorSell4,456$159.51$710,776.56View SEC Filing  
10/1/2014Daniel BradburyDirectorSell2,100$158.88$333,648.00View SEC Filing  
10/1/2014Mostafa RonaghiSVPSell10,000$159.81$1,598,100.00View SEC Filing  
9/30/2014A Blaine BowmanDirectorSell5,000$164.02$820,100.00View SEC Filing  
9/29/2014Gerald MoellerDirectorSell5,000$164.89$824,450.00View SEC Filing  
9/25/2014Jay T FlatleyCEOSell25,000$164.43$4,110,750.00View SEC Filing  
9/24/2014Christian O HenrySVPSell20,000$167.28$3,345,600.00View SEC Filing  
9/23/2014A Blaine BowmanDirectorSell5,000$168.50$842,500.00View SEC Filing  
9/16/2014A Blaine BowmanDirectorSell5,000$169.60$848,000.00View SEC Filing  
9/15/2014Daniel BradburyDirectorSell2,100$168.57$353,997.00View SEC Filing  
9/15/2014Jay T FlatleyCEOSell25,000$176.06$4,401,500.00View SEC Filing  
9/15/2014Marc StapleyCFOSell1,422$169.05$240,389.10View SEC Filing  
9/15/2014Nicholas NaclerioSVPSell2,000$169.53$339,060.00View SEC Filing  
9/9/2014A Blaine BowmanDirectorSell5,000$178.08$890,400.00View SEC Filing  
9/3/2014Christian O HenrySVPSell10,000$180.59$1,805,900.00View SEC Filing  
9/3/2014Daniel BradburyDirectorSell2,100$179.77$377,517.00View SEC Filing  
9/2/2014A Blaine BowmanDirectorSell5,000$179.67$898,350.00View SEC Filing  
9/2/2014Michel BouchardVPSell686$180.07$123,528.02View SEC Filing  
9/2/2014Mostafa RonaghiSVPSell10,000$179.66$1,796,600.00View SEC Filing  
8/28/2014Jay T FlatleyCEOSell30,000$178.98$5,369,400.00View SEC Filing  
8/26/2014A Blaine BowmanDirectorSell5,000$179.22$896,100.00View SEC Filing  
8/22/2014Daniel BradburyDirectorSell2,100$172.24$361,704.00View SEC Filing  
8/19/2014A Blaine BowmanDirectorSell5,000$171.70$858,500.00View SEC Filing  
8/15/2014Nicholas NaclerioSVPSell2,000$167.23$334,460.00View SEC Filing  
8/15/2014Roy A WhitfieldDirectorSell4,000$169.28$677,120.00View SEC Filing  
8/13/2014Christian O HenrySVPSell20,000$164.66$3,293,200.00View SEC Filing  
8/5/2014A Blaine BowmanDirectorSell5,000$159.91$799,550.00View SEC Filing  
8/4/2014Daniel BradburyDirectorSell2,100$159.77$335,517.00View SEC Filing  
8/1/2014Mostafa RonaghiSVPSell10,000$159.73$1,597,300.00View SEC Filing  
7/29/2014A Blaine BowmanDirectorSell5,000$166.89$834,450.00View SEC Filing  
7/29/2014Christian O HenrySVPSell10,000$167.40$1,674,000.00View SEC Filing  
7/24/2014Jay T FlatleyCEOSell30,000$175.43$5,262,900.00View SEC Filing  
7/23/2014Daniel BradburyDirectorSell2,100$177.87$373,527.00View SEC Filing  
7/15/2014Nicholas NaclerioSVPSell2,000$174.26$348,520.00View SEC Filing  
7/14/2014Marc StapleyCFOSell1,422$177.59$252,532.98View SEC Filing  
7/10/2014Jay T FlatleyCEOSell30,000$172.56$5,176,800.00View SEC Filing  
7/8/2014Daniel BradburyDirectorSell2,100$172.89$363,069.00View SEC Filing  
7/1/2014Mostafa RonaghiSVPSell10,000$179.47$1,794,700.00View SEC Filing  
6/30/2014Gerald MoellerDirectorSell5,000$178.97$894,850.00View SEC Filing  
6/27/2014Daniel BradburyDirectorSell2,100$171.65$360,465.00View SEC Filing  
6/26/2014Jay T FlatleyCEOSell30,000$170.11$5,103,300.00View SEC Filing  
6/24/2014Christian O HenrySVPSell10,000$172.60$1,726,000.00View SEC Filing  
6/16/2014Christian O HenrySVPSell20,000$169.73$3,394,600.00View SEC Filing  
6/16/2014Marc StapleyCFOSell1,422$169.25$240,673.50View SEC Filing  
6/12/2014Daniel BradburyDirectorSell2,100$171.17$359,457.00View SEC Filing  
6/12/2014Jay T FlatleyCEOSell30,000$172.25$5,167,500.00View SEC Filing  
6/2/2014Karin EasthamDirectorSell6,000$157.56$945,360.00View SEC Filing  
6/2/2014Michel BouchardCAOSell1,491$155.51$231,865.41View SEC Filing  
6/2/2014Mostafa RonaghiSVPSell10,000$156.93$1,569,300.00View SEC Filing  
5/22/2014Jay FlatleyCEOSell30,000$154.95$4,648,500.00View SEC Filing  
5/15/2014Nicholas NaclerioSVPSell2,000$141.72$283,440.00View SEC Filing  
5/15/2014Roy WhitfieldDirectorSell4,000$143.71$574,840.00View SEC Filing  
5/14/2014Daniel BradburyDirectorSell2,100$146.46$307,566.00View SEC Filing  
5/14/2014Marc StapleyCFOSell1,422$146.94$208,948.68View SEC Filing  
5/8/2014Jay FlatleyCEOSell30,000$143.59$4,307,700.00View SEC Filing  
5/2/2014Daniel BradburyDirectorSell2,100$139.66$293,286.00View SEC Filing  
5/1/2014Mostafa RonaghiSVPSell10,000$135.91$1,359,100.00View SEC Filing  
4/24/2014Jay FlatleyCEOSell30,000$150.80$4,524,000.00View SEC Filing  
4/15/2014Daniel BradburyDirectorSell2,100$131.29$275,709.00View SEC Filing  
4/15/2014Nicholas NaclerioSVPSell2,000$133.56$267,120.00View SEC Filing  
4/14/2014Marc StapleyCFOSell1,422$134.80$191,685.60View SEC Filing  
4/10/2014Jay FlatleyCEOSell30,000$139.90$4,197,000.00View SEC Filing  
4/4/2014Daniel BradburyDirectorSell2,100$138.44$290,724.00View SEC Filing  
4/1/2014Mostafa RonaghiSVPSell10,000$152.41$1,524,100.00View SEC Filing  
3/27/2014Jay FlatleyCEOSell30,000$140.11$4,203,300.00View SEC Filing  
3/19/2014Daniel BradburyDirectorSell2,100$161.14$338,394.00View SEC Filing  
3/17/2014Gerald MoellerDirectorSell10,000$161.92$1,619,200.00View SEC Filing  
3/17/2014Nicholas NaclerioSVPSell2,000$163.65$327,300.00View SEC Filing  
3/14/2014Marc StapleyCFOSell1,422$163.35$232,283.70View SEC Filing  
3/13/2014Jay FlatleyCEOSell30,000$165.96$4,978,800.00View SEC Filing  
3/11/2014Christian HenrySVPSell3,000$167.16$501,480.00View SEC Filing  
3/11/2014Michel BouchardCAOSell2,168$167.21$362,511.28View SEC Filing  
3/3/2014Michel BouchardCAOSell2,994$176.81$529,369.14View SEC Filing  
2/25/2014Michel BouchardCAOSell24,505$176.13$4,316,065.65View SEC Filing  
2/24/2014Roy WhitfieldDirectorSell2,000$175.26$350,520.00View SEC Filing  
2/18/2014Nicholas NaclerioSVPSell2,000$169.77$339,540.00View SEC Filing  
2/13/2014Jay FlatleyCEOSell30,000$160.43$4,812,900.00View SEC Filing  
2/7/2014Jay FlatleyCEOSell5,000$152.23$761,150.00View SEC Filing  
1/31/2014Marc StapleyCFOSell20,038$151.32$3,032,150.16View SEC Filing  
1/23/2014Jay FlatleyCEOSell30,000$142.30$4,269,000.00View SEC Filing  
1/9/2014Jay FlatleyCEOSell30,000$114.77$3,443,100.00View SEC Filing  
12/26/2013Jay FlatleyCEOSell30,000$107.88$3,236,400.00View SEC Filing  
12/17/2013Gregory HeathSVPSell1,875$102.68$192,525.00View SEC Filing  
10/30/2013Christian O HenrySVPSell6,000$93.29$559,740.00View SEC Filing  
10/30/2013David R WaltDirectorSell5,000$93.02$465,100.00View SEC Filing  
10/28/2013William H RastetterDirectorSell20,000$92.37$1,847,400.00View SEC Filing  
10/24/2013Jay T FlatleyCEOSell30,000$92.32$2,769,600.00View SEC Filing  
10/22/2013Nicholas NaclerioSVPSell20,000$90.00$1,800,000.00View SEC Filing  
10/17/2013Gregory HeathSVPSell1,875$82.09$153,918.75View SEC Filing  
10/16/2013David R WaltDirectorSell5,000$82.59$412,950.00View SEC Filing  
10/15/2013Nicholas NaclerioSVPSell4,000$81.32$325,280.00View SEC Filing  
10/10/2013Christian HenrySVPSell6,000$77.73$466,380.00View SEC Filing  
10/10/2013Jay FlatleyCEOSell20,000$77.75$1,555,000.00View SEC Filing  
10/2/2013David R WaltDirectorSell5,000$80.58$402,900.00View SEC Filing  
9/18/2013David WaltDirectorSell5,000$83.11$415,550.00View SEC Filing  
9/17/2013Gregory HeathSVPSell1,875$85.20$159,750.00View SEC Filing  
9/16/2013Jay FlatleyCEOSell30,000$83.27$2,498,100.00View SEC Filing  
9/16/2013Nicholas NaclerioSVPSell4,000$85.00$340,000.00View SEC Filing  
9/10/2013Gregory HeathSVPSell1,875$82.00$153,750.00View SEC Filing  
9/9/2013Paul L BianchiSVPSell1,627$79.03$128,581.81View SEC Filing  
9/5/2013Christian O HenrySVPSell9,000$78.17$703,530.00View SEC Filing  
9/4/2013David R WaltDirectorSell5,000$77.18$385,900.00View SEC Filing  
9/3/2013Nicholas NaclerioSVPSell59,000$76.91$4,537,690.00View SEC Filing  
9/3/2013Roy A WhitfieldDirectorSell2,000$78.49$156,980.00View SEC Filing  
8/30/2013Mark LewisSVPSell5,000$78.12$390,600.00View SEC Filing  
8/22/2013Jay FlatleyCEOSell20,000$78.65$1,573,000.00View SEC Filing  
8/21/2013David WaltDirectorSell5,000$78.34$391,700.00View SEC Filing  
8/15/2013Nicholas NaclerioSVPSell2,000$78.43$156,860.00View SEC Filing  
8/8/2013Jay FlatleyCEOSell20,000$78.07$1,561,400.00View SEC Filing  
8/7/2013David WaltDirectorSell5,000$78.29$391,450.00View SEC Filing  
8/2/2013Michel BouchardVPSell11,465$80.64$924,537.60View SEC Filing  
7/25/2013Christian O HenrySVPSell11,462$80.89$927,161.18View SEC Filing  
7/25/2013Jay T FlatleyCEOSell20,000$81.01$1,620,200.00View SEC Filing  
7/24/2013David R WaltDirectorSell4,600$81.44$374,624.00View SEC Filing  
7/24/2013Gregory HeathSVPSell209,533$82.00$17,181,706.00View SEC Filing  
7/24/2013Michel BouchardVPSell9,789$79.28$776,071.92View SEC Filing  
7/15/2013Nicholas NaclerioSVPSell2,000$74.50$149,000.00View SEC Filing  
7/11/2013Jay T FlatleyCEOSell20,000$74.90$1,498,000.00View SEC Filing  
7/11/2013Mostafa RonaghiSVPSell24,000$74.95$1,798,800.00View SEC Filing  
7/10/2013David R WaltDirectorSell5,000$74.26$371,300.00View SEC Filing  
7/10/2013Michel BouchardVPSell3,618$74.30$268,817.40View SEC Filing  
7/9/2013Christian O HenrySVPSell9,000$74.01$666,090.00View SEC Filing  
6/27/2013Jay T FlatleyCEOSell20,000$74.96$1,499,200.00View SEC Filing  
6/26/2013David R WaltDirectorSell5,000$75.36$376,800.00View SEC Filing  
6/26/2013Michel BouchardVPSell4,272$75.06$320,656.32View SEC Filing  
6/25/2013Tristan OrpinSVPSell35,000$71.98$2,519,300.00View SEC Filing  
6/17/2013Nicholas NaclerioSVPSell2,000$68.56$137,120.00View SEC Filing  
6/14/2013Christian O HenrySVPSell25,959$68.10$1,767,807.90View SEC Filing  
6/13/2013Jay T FlatleyCEOSell20,000$66.49$1,329,800.00View SEC Filing  
6/13/2013Tristan OrpinSVPSell47,667$66.55$3,172,238.85View SEC Filing  
6/12/2013David R WaltDirectorSell5,000$67.67$338,350.00View SEC Filing  
6/12/2013Michel BouchardVPSell5,170$68.64$354,868.80View SEC Filing  
6/11/2013Mostafa RonaghiSVPSell24,000$69.01$1,656,240.00View SEC Filing  
6/3/2013Karin EasthamDirectorSell10,000$70.34$703,400.00View SEC Filing  
5/31/2013Mark L LewisSVPSell13,000$71.72$932,360.00View SEC Filing  
5/30/2013Matthew L PosardSVPSell2,836$70.80$200,788.80View SEC Filing  
5/29/2013David R WaltDirectorSell5,000$70.92$354,600.00View SEC Filing  
5/29/2013Michel BouchardVPSell6,276$71.02$445,721.52View SEC Filing  
5/21/2013Jay T FlatleyCEOSell24,000$69.39$1,665,360.00View SEC Filing  
5/20/2013Marc StapleyCFOSell2,843$73.38$208,619.34View SEC Filing  
5/15/2013David R WaltDirectorSell5,000$70.73$353,650.00View SEC Filing  
5/15/2013Michel BouchardVPSell14,241$70.71$1,006,981.11View SEC Filing  
5/15/2013Nicholas NaclerioSVPSell2,000$70.72$141,440.00View SEC Filing  
5/13/2013Mostafa RonaghiSVPSell24,000$68.83$1,651,920.00View SEC Filing  
5/10/2013Tristan OrpinSVPSell25,000$69.60$1,740,000.00View SEC Filing  
5/9/2013Jay T FlatleyCEOSell20,000$66.63$1,332,600.00View SEC Filing  
5/7/2013Tristan OrpinSVPSell5,000$65.68$328,400.00View SEC Filing  
4/8/2013Christian CabouSVPSell16,500$55.00$907,500.00View SEC Filing  
4/8/2013Marc StapleyCFOSell9,175$55.00$504,625.00View SEC Filing  
4/8/2013William H RastetterDirectorSell20,000$54.95$1,099,000.00View SEC Filing  
3/11/2013Marc StapleyCFOSell4,468$53.71$239,976.28View SEC Filing  
11/8/2012Jay T FlatleyCEOSell5,000$47.99$239,950.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Illumina (NASDAQ ILMN) News Headlines

Source:
DateHeadline
Biotech ETF Experiences Big OutflowBiotech ETF Experiences Big Outflow
www.nasdaq.com - December 15 at 3:17 PM
Heres Why You Should Invest in Illumina (ILMN) Stock NowHere's Why You Should Invest in Illumina (ILMN) Stock Now
finance.yahoo.com - December 15 at 3:17 PM
Illumina, Inc. breached its 50 day moving average in a Bearish Manner : ILMN-US : December 15, 2017Illumina, Inc. breached its 50 day moving average in a Bearish Manner : ILMN-US : December 15, 2017
finance.yahoo.com - December 15 at 3:17 PM
ETFs with exposure to Illumina, Inc. : December 14, 2017ETFs with exposure to Illumina, Inc. : December 14, 2017
finance.yahoo.com - December 14 at 3:16 PM
Morgan Stanley Increases Illumina (ILMN) Price Target to $135.00Morgan Stanley Increases Illumina (ILMN) Price Target to $135.00
www.americanbankingnews.com - December 14 at 11:06 AM
Is Illumina, Inc. a Buy?Is Illumina, Inc. a Buy?
www.fool.com - December 13 at 9:49 AM
Zacks: Analysts Expect Illumina, Inc. (ILMN) Will Announce Quarterly Sales of $735.16 MillionZacks: Analysts Expect Illumina, Inc. (ILMN) Will Announce Quarterly Sales of $735.16 Million
www.americanbankingnews.com - December 12 at 2:50 AM
The case for Pacific Biosciences - Motley FoolThe case for Pacific Biosciences - Motley Fool
www.fool.com - December 11 at 3:15 PM
Better Buy: Illumina, Inc. vs. Pacific BiosciencesBetter Buy: Illumina, Inc. vs. Pacific Biosciences
www.fool.com - December 11 at 2:31 PM
Illumina, Inc. (ILMN) Expected to Announce Earnings of $1.18 Per ShareIllumina, Inc. (ILMN) Expected to Announce Earnings of $1.18 Per Share
www.americanbankingnews.com - December 10 at 9:37 PM
Illumina (ILMN) Downgraded to "Hold" at BidaskClubIllumina (ILMN) Downgraded to "Hold" at BidaskClub
www.americanbankingnews.com - December 10 at 2:30 PM
Illumina, Inc. (ILMN) Given Consensus Recommendation of "Buy" by BrokeragesIllumina, Inc. (ILMN) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - December 8 at 8:14 PM
Shares of Illumina (ILMN) Raised to Strong Buy From a Buy - Investorplace.comShares of Illumina (ILMN) Raised to Strong Buy From a Buy - Investorplace.com
investorplace.com - December 8 at 5:54 AM
Disney adds two tech execs to boardDisney adds two tech execs to board
finance.yahoo.com - December 8 at 5:54 AM
Illumina, Inc. (ILMN) Director Jay T. Flatley Sells 20,000 SharesIllumina, Inc. (ILMN) Director Jay T. Flatley Sells 20,000 Shares
www.americanbankingnews.com - December 7 at 8:39 PM
Shares of Illumina (ILMN) Raised to Strong Buy From a BuyShares of Illumina (ILMN) Raised to Strong Buy From a Buy
investorplace.com - December 7 at 10:07 AM
Insider Selling: Illumina, Inc. (ILMN) SVP Sells 145 Shares of StockInsider Selling: Illumina, Inc. (ILMN) SVP Sells 145 Shares of Stock
www.americanbankingnews.com - December 6 at 9:26 PM
Marc Stapley Sells 2,000 Shares of Illumina, Inc. (ILMN) StockMarc Stapley Sells 2,000 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - December 6 at 8:52 PM
Why Illumina Jumped 9.8% in NovemberWhy Illumina Jumped 9.8% in November
finance.yahoo.com - December 6 at 3:16 PM
Robert S. Epstein Sells 1,250 Shares of Illumina, Inc. (ILMN) StockRobert S. Epstein Sells 1,250 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - December 5 at 9:28 PM
Omead Ostadan Sells 3,540 Shares of Illumina, Inc. (ILMN) StockOmead Ostadan Sells 3,540 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - December 5 at 8:58 PM
Illumina (ILMN) Upgraded to Buy by Zacks Investment ResearchIllumina (ILMN) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - December 5 at 12:38 PM
Global Market Study on ISO Certification: Construction Industry Segment to Reach a Market Valuation of About US$ 2.2 Bn by 2018 EndGlobal Market Study on ISO Certification: Construction Industry Segment to Reach a Market Valuation of About US$ 2.2 Bn by 2018 End
www.prnewswire.com - December 4 at 9:21 PM
Illumina (ILMN) a Buy on Superior Earnings Growth - Investorplace.comIllumina (ILMN) a Buy on Superior Earnings Growth - Investorplace.com
investorplace.com - December 1 at 3:17 PM
Global Automotive Combination Switch Market 2017-2021 - Latest Trend Gaining Momentum is Increased Use of Illuminated Automotive SwitchesGlobal Automotive Combination Switch Market 2017-2021 - Latest Trend Gaining Momentum is Increased Use of Illuminated Automotive Switches
www.prnewswire.com - November 30 at 3:58 PM
Illumina Opens Commercial And Customer Training Center In FranceIllumina Opens Commercial And Customer Training Center In France
www.nasdaq.com - November 30 at 3:16 PM
ETFs with exposure to Illumina, Inc. : November 30, 2017ETFs with exposure to Illumina, Inc. : November 30, 2017
finance.yahoo.com - November 30 at 3:16 PM
Illumina (ILMN) a Buy on Superior Earnings GrowthIllumina (ILMN) a Buy on Superior Earnings Growth
investorplace.com - November 30 at 10:12 AM
Why 2017 Was a Year to Remember for Illumina, Inc. - Motley FoolWhy 2017 Was a Year to Remember for Illumina, Inc. - Motley Fool
www.fool.com - November 29 at 3:15 PM
Why 2017 Was a Year to Remember for Illumina, Inc.Why 2017 Was a Year to Remember for Illumina, Inc.
finance.yahoo.com - November 29 at 3:15 PM
Illumina Opens First Commercial and Customer Training Center in France - Business Wire (press release)Illumina Opens First Commercial and Customer Training Center in France - Business Wire (press release)
www.businesswire.com - November 29 at 5:46 AM
Illumina Reaches Analyst Target PriceIllumina Reaches Analyst Target Price
www.nasdaq.com - November 28 at 9:34 AM
Illumina, Inc. (ILMN) Director Sells $4,227,000.00 in StockIllumina, Inc. (ILMN) Director Sells $4,227,000.00 in Stock
www.americanbankingnews.com - November 24 at 7:23 PM
$735.16 Million in Sales Expected for Illumina, Inc. (ILMN) This Quarter$735.16 Million in Sales Expected for Illumina, Inc. (ILMN) This Quarter
www.americanbankingnews.com - November 24 at 2:14 AM
Illumina’s (ILMN) High-Level Earnings Visibility Keep it a BuyIllumina’s (ILMN) High-Level Earnings Visibility Keep it a Buy
investorplace.com - November 23 at 4:54 PM
Illumina’s (ILMN) High-Level Earnings Visibility Keep it a BuyIllumina’s (ILMN) High-Level Earnings Visibility Keep it a Buy
investorplace.com - November 23 at 10:24 AM
$1.18 EPS Expected for Illumina, Inc. (ILMN) This Quarter$1.18 EPS Expected for Illumina, Inc. (ILMN) This Quarter
www.americanbankingnews.com - November 22 at 11:08 PM
Q1 2018 EPS Estimates for Illumina, Inc. (ILMN) Lifted by William BlairQ1 2018 EPS Estimates for Illumina, Inc. (ILMN) Lifted by William Blair
www.americanbankingnews.com - November 22 at 9:52 AM
Illumina Wins UK Patent Suit Against Premaitha Health, Ariosa DiagnosticsIllumina Wins UK Patent Suit Against Premaitha Health, Ariosa Diagnostics
www.nasdaq.com - November 22 at 6:01 AM
Illumina (ILMN) Wins Infringement Suit Against Premaitha Health and Ariosa Diagnostics - StreetInsider.comIllumina (ILMN) Wins Infringement Suit Against Premaitha Health and Ariosa Diagnostics - StreetInsider.com
www.streetinsider.com - November 22 at 12:59 AM
Illumina (ILMN) Wins Infringement Suit Against Premaitha Health and Ariosa DiagnosticsIllumina (ILMN) Wins Infringement Suit Against Premaitha Health and Ariosa Diagnostics
www.streetinsider.com - November 21 at 7:58 PM
Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.
finance.yahoo.com - November 21 at 7:58 PM
William Blair Comments on Illumina, Inc.s FY2017 Earnings (ILMN)William Blair Comments on Illumina, Inc.'s FY2017 Earnings (ILMN)
www.americanbankingnews.com - November 21 at 7:58 AM
ETFs with exposure to Illumina, Inc. : November 20, 2017ETFs with exposure to Illumina, Inc. : November 20, 2017
finance.yahoo.com - November 20 at 8:14 PM
The Illuminating Company Announces "Merry & Bright" Holiday Lights Photo ContestThe Illuminating Company Announces "Merry & Bright" Holiday Lights Photo Contest
www.prnewswire.com - November 20 at 2:36 PM
Illumina’s (ILMN) Strong Earnings Visibility Keep it a BuyIllumina’s (ILMN) Strong Earnings Visibility Keep it a Buy
investorplace.com - November 18 at 2:10 AM
Illuminas (ILMN) Strong Earnings Visibility Keep it a Buy ... - Investorplace.comIllumina's (ILMN) Strong Earnings Visibility Keep it a Buy ... - Investorplace.com
www.investorplace.com - November 17 at 6:49 AM
Insider Selling: Illumina, Inc. (ILMN) EVP Sells 2,000 Shares of StockInsider Selling: Illumina, Inc. (ILMN) EVP Sells 2,000 Shares of Stock
www.americanbankingnews.com - November 16 at 8:37 PM
Illumina’s (ILMN) Strong Earnings Visibility Keep it a BuyIllumina’s (ILMN) Strong Earnings Visibility Keep it a Buy
investorplace.com - November 16 at 10:22 AM
Illumina, Inc. (ILMN) SVP Oene Mark Van Sells 1,232 SharesIllumina, Inc. (ILMN) SVP Oene Mark Van Sells 1,232 Shares
www.americanbankingnews.com - November 15 at 10:29 PM

SEC Filings

Illumina (NASDAQ:ILMN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Illumina (NASDAQ:ILMN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Illumina (NASDAQ ILMN) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.